Aneurysm
Valor Medical Receives Approval for First Clinical Trial Site
Published in Medical Device Business Week, February 6th, 2008
Valor Medical, an emerging medical device company that has developed an injectable device for the treatment of cerebral aneurysms, announced that approval for the first clinical trial in Europe has been received. Clark Adams, CEO, stated, "The approval to begin human implants is a major milestone for Valor Medical. We expect to be treating patients within the next 60 days and should have a second trial site approved at that time. Valor will also soon submit an IDE application to the FDA for approval to begin human trials in the United States."
The technology that Valor developed, Neucrylate(TM), is a liquid that is injected into a cerebral aneurysm through a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Algorithms
Scientists at Medtronic, Inc. discuss research in algorithms - Alzheimer Disease
Innovative Brain Scanning for Alzheimer's Screening Unveiled - Artificial Organs
Abiomed Receives HDE Supplement Approval for AbioCor(R) Artificial Heart - Atrial Fibrillation
Independent Clinical Trial Finds HIFU Surgical Ablation Effective in Treating Atrial Fibrillation - Biomedicine
Opnext Introduces Red Laser Diode for Biomedical Measurement and Future Medical Applications - Biotechnology Business
Abiomed to Host Symposium on Spectrum of Heart Recovery Technologies at STS 2008 - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
